The European-OrganizationFor-Research-And-Treatment-Of-Cancer QLQ-C30 -A Quality-Of-Life Instrument for Use in International Clinical-Trials in Oncology, J. Natl. Cancer Inst, vol.85, pp.365-76, 1993. ,
Place de l'anatomopathologie dans l'évaluation de la réponse à la chimiothérapie néoadjuvante : marqueurs pronostiques et prédictifs. L'exemple du cancer du sein, Bull. Cancer (Paris), vol.93, issue.7, pp.663-668, 2006. ,
Cardiotoxicity of systemic agents used in breast cancer, Breast Edinb. Scotl, vol.23, issue.4, pp.317-328, 2014. ,
Lymphovascular invasion as a negative prognostic factor for triple-negative breast cancer after surgery, Radiat. Oncol. J, vol.35, issue.4, pp.332-339, 2017. ,
Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES), Acta Endosc, vol.28, issue.2, pp.151-155, 1998. ,
, ANAES, 2002.
A Pilot Study of Predictive Markers of Chemotherapy-Related Amenorrhea Among Premenopausal Women with Early Stage Breast Cancer, Cancer Invest, vol.26, issue.3, pp.286-295, 2008. ,
Understanding and Treating Triple-Negative Breast Cancer, Oncol. Williston Park N, vol.22, issue.11, pp.1233-1243, 2008. ,
Breast Cancer Before Age 40 Years, Semin. Oncol, vol.36, issue.3, pp.237-249, 2009. ,
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial, JAMA, vol.291, issue.14, pp.1701-1712, 2004. ,
The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer, Eur. J. Cancer, vol.87, pp.58-64, 2017. ,
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies, Am. J. Hum. Genet, vol.72, issue.5, pp.1117-1130, 2003. ,
ASCO Guideline Update Recommends Tamoxifen for Up to 10 Years for Women With Non-Metastatic Hormone Receptor Positive Breast Cancer, 2014. ,
, Surgical guidelines for the management of breast cancer, Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol, vol.35, pp.1-22, 2009.
Quality of Life in Diverse Groups of Midlife Women: Assessing the Influence of Menopause, Health Status and Psychosocial and Demographic Factors, Qual. Life Res, vol.13, issue.5, pp.933-946, 2004. ,
Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study, Cancer Causes Control CCC, vol.29, issue.6, pp.495-505, 2018. ,
Early Stage Triple-Negative Breast Cancer: Imaging and Clinical-Pathologic Factors Associated with Recurrence, Radiology, vol.278, issue.2, pp.356-364, 2016. ,
A quantitative and cytological study of germ cells in human ovaries, Proc. R. Soc. Lond. B Biol. Sci, vol.158, issue.972, pp.417-433, 1963. ,
Recommandations pour l'évaluation immunohistochimique des récepteurs hormonaux sur coupes en paraffine dans les carcinomes mammaires Mise à jour 1999, 1999. ,
BI-RADS 2013 en mammographie : petit guide des nouveautés, Imag. Femme, vol.25, issue.1, pp.1-7, 2015. ,
The Endocrinology of the Menstrual Cycle, Human Fertility: Methods and Protocols, pp.145-169, 2014. ,
Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry, Cancer, vol.109, issue.9, pp.1721-1728, 2007. ,
Breast cancer and hormonereplacement therapy in the Million Women Study, Lancet Lond. Engl, vol.362, issue.9382, pp.419-427, 2003. ,
Epidemiology of Endocrine-Related Risk Factors for Breast Cancer, J. Mammary Gland Biol. Neoplasia, vol.7, issue.1, pp.3-15, 2002. ,
Impact pronostique du statut des récepteurs hormonaux et HER2 sur la survie des femmes atteintes d'un cancer du sein de stade IV : étude à partir du registre spécialisé de Côte-d, Or. Rev. DÉpidémiologie Santé Publique, vol.62, pp.213-214, 2014. ,
Estimation nationale de l'incidence et de la mortalité par cancer en France entre 1980 et 2012 -Partie 1 -Tumeurs solides -Ref : RAPTUMSOL13 | Institut National Du Cancer, 2013. ,
Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer, J. Clin. Oncol, vol.14, issue.5, pp.1718-1729, 1996. ,
Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival, pp.6-5767, 1975. ,
Diseaserelated outcomes with long-term follow-up: an updated analysis of the intergroup exemestane study, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.30, issue.7, pp.709-717, 2012. ,
Quantitative morphological investigations of the follicular system in women; variations at different ages, Acta Anat. (Basel), vol.14, issue.1-2, pp.108-123, 1952. ,
Intrusiveness of illness and quality of life in young women with breast cancer, Psychooncology, vol.7, issue.2, pp.89-100, 1998. ,
Role of physical activity and sport in oncology: scientific commission of the National Federation Sport and Cancer CAMI, Crit. Rev. Oncol. Hematol, vol.94, issue.1, pp.74-86, 2015. ,
Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.15, issue.3, pp.974-986, 1997. ,
Cigarette smoking and the risk of breast cancer, Eur. J. Cancer Prev. Off. J. Eur. Cancer Prev. Organ. ECP, vol.5, issue.3, pp.159-164, 1996. ,
Family history and risk of breast cancer: an analysis accounting for family structure, Breast Cancer Res. Treat, vol.165, issue.1, pp.193-200, 2017. ,
Menstrual factors and risk of breast cancer, Cancer Invest, vol.6, issue.3, pp.245-254, 1988. ,
The Impact of Mammographic Screening on Breast Cancer Mortality in Europe: A Review of Observational Studies, J. Med. Screen, vol.19, pp.14-25, 2012. ,
Ovarian Aging: Mechanisms and Clinical Consequences, Endocr. Rev, vol.30, issue.5, pp.465-493, 2009. ,
Survival with metastatic breast cancer based on initial presentation, de novo versus relapsed, Breast Cancer Res. Treat, vol.161, issue.3, pp.549-556, 2017. ,
Unpredictable endocrinology of the menopause transition: clinical, diagnostic and management implications, Menopause Int, vol.17, issue.4, pp.153-154, 2011. ,
Adjuvant endocrine therapy for women with hormone receptorpositive breast cancer: american society of clinical oncology clinical practice guideline focused update, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.32, issue.21, pp.2255-2269, 2014. ,
Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.21, issue.7, pp.1688-1698, 2015. ,
, Cancer du sein chez l'homme -Cancer du sein | Institut National Du Cancer, 2018.
, Comprehensive molecular portraits of human breast tumours, Nature, vol.490, issue.7418, pp.61-70, 2012.
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes, Clin. Cancer Res, vol.13, issue.8, pp.2329-2334, 2007. ,
Dietary patterns and breast cancer risk: a study in 2 cohorts, Am. J. Clin. Nutr, vol.101, issue.4, pp.817-823, 2015. ,
Type of breast cancer diagnosis, screening, and survival, Clin. Breast Cancer, vol.14, issue.4, pp.235-240, 2014. ,
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.11, issue.3, pp.570-579, 1993. ,
, National Center for Chronic Disease Prevention and Health Promotion (US), and Office on Smoking and Health (US), Centers for Disease Control and Prevention (US)
, How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General, 2018.
Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies, The Lancet, vol.347, issue.9017, pp.1713-1727, 1996. ,
Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer, Adv. Radiat. Oncol, vol.2, issue.2, pp.105-109, 2017. ,
Organotropism: new insights into molecular mechanisms of breast cancer metastasis, NPJ Precis. Oncol, vol.2, issue.1, 2018. ,
, , 2019.
, Gynecol. Obstet. Fertil. Senol, vol.47, issue.2, pp.91-92
, , 2016.
, Gynécologie Obstétrique Fertil, vol.44, issue.7, pp.377-384
Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate, Am. J. Clin. Oncol, vol.16, issue.3, pp.223-228, 1993. ,
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial, JAMA, vol.289, issue.24, pp.3243-3253, 2003. ,
A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN), Cancer J. Sudbury Mass, vol.14, issue.2, pp.128-132, 2008. ,
Chimiothérapie néo-adjuvante. Expérience du centre Jean-Perrin. Importance de la tumeur résiduelle et de la rémission histologique complète, pp.293-306, 2006. ,
Evaluate the subjective experience of the disease and its treatment in the partners of young women with non-metastatic breast cancer, Eur. J. Cancer Care (Engl.), vol.25, issue.5, pp.734-743, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01470061
Hormonal contraception and risk of cancer, Hum. Reprod. Update, vol.16, issue.6, pp.631-650, 2010. ,
Steroid receptors and other prognostic factors in primary breast cancer, Semin. Oncol, vol.15, issue.2, pp.20-25, 1988. ,
Steroid receptors and proliferation in the human breast, Steroids, vol.68, pp.789-794, 2003. ,
Estrogen and the risk of breast cancer, N. Engl. J. Med, vol.344, issue.4, pp.276-285, 2001. ,
, Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer, vol.26, pp.1533-1546, 2015.
Family History, Age, and Risk of Breast Cancer: Prospective Data From the Nurses' Health Study, JAMA, vol.270, issue.3, pp.338-343, 1993. ,
, Collège National des Gynécologues et Obstétriciens Français, J. Gynécologie Obstétrique Biol. Reprod, vol.34, issue.5, p.513, 2005.
On the anatomy of the breast -Of the internal parts of the breast, or mammary gland. Anat. Breast Sir Astley Paston Cooper 1840, 1840. ,
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis, Lancet Lond. Engl, vol.384, issue.9938, pp.62422-62430, 2014. ,
IMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer, Future Oncol. Lond. Engl, 2019. ,
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer, JAMA Oncol, vol.3, issue.9, pp.1190-1196, 2017. ,
Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy, Breast Cancer Res. Treat, vol.76, issue.1, pp.37-45, 2002. ,
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial, Lancet Oncol, vol.11, issue.12, pp.70257-70263, 2010. ,
Dietary Patterns and Breast Cancer Risk: A Systematic Review, Anticancer Res, vol.38, issue.6, pp.3209-3222, 2018. ,
, Longer Against Shorter (ATLAS) Collaborative Group. 2013. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial, vol.381, pp.61963-61964
, Menopause. Nat. Rev. Dis. Primer, vol.1, p.15004, 2015.
Survival among women with triple receptor-negative breast cancer and brain metastases, Ann. Oncol, vol.20, issue.4, pp.621-627, 2009. ,
Adjuvant tamoxifen in postmenopausal breast cancer: preliminary results of a randomized trial, Breast Cancer Res. Treat, vol.7, issue.2, pp.105-109, 1986. ,
A prospective population-based study of menopausal symptoms, Obstet. Gynecol, vol.96, issue.3, pp.351-358, 2000. ,
Pattern of metastatic spread in triple-negative breast cancer, Breast Cancer Res. Treat, vol.115, issue.2, pp.423-428, 2009. ,
Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer, Eur. J. Cancer, vol.79, pp.72-80, 2017. ,
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.25, issue.3, pp.611-618, 2014. ,
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno, Oncology Biomarker Working Group on Breast Cancer. Semin. Cancer Biol, vol.52, pp.16-25, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01675219
A Retrospective Study on the Onset of Menopause after Chemotherapy: Analysis of Data Extracted from the Jean Perrin Comprehensive Cancer Center Database Concerning 345 Young Breast Cancer Patients Diagnosed between, Oncology, vol.92, issue.5, pp.255-263, 1994. ,
URL : https://hal.archives-ouvertes.fr/hal-01675233
ACR BI-RADS® Atlas 5th Edition ebook, 2013. ,
Active and passive cigarette smoking and breast cancer risk: Results from the EPIC cohort, Int. J. Cancer, vol.134, issue.8, pp.1871-1888, 2014. ,
Metaanalysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.28, issue.3, pp.509-518, 2010. ,
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group, JNCI J. Natl. Cancer Inst, vol.103, issue.22, pp.1656-1664, 2011. ,
, Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women, N. Engl. J. Med, vol.319, issue.26, pp.1681-1692, 1988.
, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, Lancet Lond. Engl, vol.365, issue.9472, pp.1687-1717, 2005.
, Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials, Lancet, vol.378, issue.9793, pp.60993-61001, 2011.
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials, Lancet Lond. Engl, vol.378, issue.9804, pp.61629-61631, 2011. ,
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: metaanalysis of individual patient data for 8135 women in 22 randomised trials, Lancet Lond. Engl, vol.383, issue.9935, pp.60488-60496, 2014. ,
Réponse du Groupe technique national sur le dépistage du cancer du sein, Bull. Cancer (Paris), vol.91, issue.7, pp.656-656, 2004. ,
Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up, Histopathology, vol.20, issue.6, pp.479-489, 1992. ,
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with longterm follow-up, Histopathology, vol.19, issue.5, pp.403-410, 1991. ,
, Available from https://ecis.jrc.ec.europa.eu/explorer.php?$1-IT$2-127$4-2$3-29$6-0,85$5-2004, 2012.
, Fact Sheets by Cancer, p.10, 2018.
Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause, Hum. Reprod. Oxf. Engl, vol.7, issue.10, pp.1342-1346, 1992. ,
Long-term health consequences of premature or early menopause and considerations for management, Climacteric J. Int. Menopause Soc, vol.18, issue.4, pp.483-491, 2015. ,
Harrison's Principles of Internal Medicine, 2008. ,
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance, Health Qual. Life Outcomes, vol.4, p.79, 2006. ,
Tumour size is the only predictive factor of distant recurrence after pathological complete response to neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancers: A sub-study of EORTC 10994/BIG 1-00 phase III trial, Eur. J. Cancer, vol.51, issue.3, pp.301-309, 2015. ,
Quality of life: its definition and measurement, Res. Dev. Disabil, vol.16, issue.1, pp.51-74, 1995. ,
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis -ScienceDirect, p.29, 2018. ,
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, Int. J. Cancer, vol.136, issue.5, pp.359-386, 2014. ,
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012, Eur. J. Cancer, vol.49, issue.6, pp.1374-1403, 2013. ,
Abstract P5-12-09: The ?5% cut-off reveals tumor PD-L1 positivity as potential selection biomarker for patient enrollment into the trials evaluating anti-PD-1 or anti-PD-L1 agents in neoadjuvant treatment of triple negative breast cancer, Cancer Res, vol.79, 2004. ,
Report of the International Workshop on Screening for Breast Cancer, J. Natl. Cancer Inst, vol.85, issue.20, pp.1644-1656, 1993. ,
Cancers du sein : le diagnostic | Fondation ARC pour la recherche sur le cancer. Available from /cancer/cancer-sein/diagnostic-cancer, 2018. ,
Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane, Cancer, vol.104, issue.8, pp.1575-1579, 2005. ,
Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort, Int. J. Cancer, vol.114, issue.3, pp.448-454, 2005. ,
URL : https://hal.archives-ouvertes.fr/inserm-00129104
Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort, Int. J. Cancer, vol.114, issue.3, pp.448-454 ,
URL : https://hal.archives-ouvertes.fr/inserm-00129104
Follicular phase hormone levels and menstrual bleeding status in the approach to menopause, Fertil. Steril, vol.83, issue.2, pp.383-392, 2005. ,
Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects, Br. J. Sports Med, vol.42, issue.8, pp.636-647, 2008. ,
Stage 0 to stage III breast cancer in young women11No competing interests declared, J. Am. Coll. Surg, vol.190, issue.5, pp.523-529, 2000. ,
Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis, J. Cancer Res. Clin. Oncol, vol.139, issue.5, pp.853-860, 2013. ,
Breast Cancer in Younger Women: Reproductive and Late Health Effects of Treatment, J. Clin. Oncol, vol.21, issue.22, pp.4184-4193, 2003. ,
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67, J. Immunol. Baltim. Md, vol.133, issue.4, pp.1710-1715, 1950. ,
The Spectrum of Triple-Negative Breast Disease: High-and Low-Grade Lesions, Am. J. Pathol, vol.187, issue.10, pp.2139-2151, 2017. ,
Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments, Clin. Breast Cancer, vol.18, issue.5, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01834391
Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA, Cancer J. Clin, vol.67, issue.4, pp.290-303, 2017. ,
Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial, JAMA, vol.305, issue.6, pp.569-575, 2011. ,
, GLOBOCAN 2012 age-specific table, p.10, 2012.
, GLOBOCAN 2012 age-specific table. (n.d.). Available from, p.17, 2017.
Summary of the Consensus Discussion, Breast Care, vol.6, issue.2, pp.136-141, 2011. ,
Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort, Eur. J. Cancer, vol.96, pp.17-24, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01930014
Factors Related to Age at Natural Menopause: Longitudinal Analyses From SWAN, Am. J. Epidemiol, vol.178, issue.1, pp.70-83, 2013. ,
HERA) Trial Study Team. 2013a. 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial, Lancet Lond. Engl, vol.382, issue.9897, pp.61094-61100 ,
, and Panel members. 2005. Meeting highlights: international expert consensus on the primary therapy of early breast cancer, vol.16, pp.1569-1583, 2005.
, Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer, vol.24, pp.2206-2223, 2013.
Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis, J. Natl. Cancer Inst, vol.110, issue.1, 2018. ,
Premature Menopause in Young Breast Cancer Survivors: Effects on Quality of Life Not Well Studied, Oncol. Times, vol.26, issue.14, p.35, 2004. ,
Risk of menopause during the first year after breast cancer diagnosis, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.17, issue.8, pp.2365-2370, 1999. ,
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.26, issue.12, pp.1948-1955, 2008. ,
Impact of cancer therapies on ovarian reserve, Fertil. Steril, vol.97, issue.1, pp.134-140, 2012. ,
Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients, Breast Edinb. Scotl, vol.44, pp.33-38, 2019. ,
Predictive Factors of Response in HER2-Positive Breast Cancer Treated by Neoadjuvant Therapy, J. Oncol, 2013. ,
The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer, Crit. Rev. Oncol. Hematol, vol.89, issue.2, pp.231-241, 2014. ,
Non-hormonal treatment strategies for vasomotor symptoms: a critical review, Drugs, vol.71, issue.3, pp.287-304, 2011. ,
, Br. J. Cancer, vol.87, issue.11, pp.1234-1245
, Bone Imaging in Metastatic Breast Cancer. J. Clin. Oncol, vol.22, issue.14, pp.2942-2953, 2004.
of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer, J. Clin. Oncol, vol.28, issue.16, pp.2784-2795, 2010. ,
The hallmarks of cancer, Cell, vol.100, issue.1, pp.57-70, 2000. ,
Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011. ,
A prospective study of oral contraceptive use and risk of breast cancer (Nurses' Health Study, United States), Cancer Causes Control, vol.8, issue.1, pp.65-72, 1997. ,
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer, Oncogene, vol.19, issue.53, pp.6102-6114, 2000. ,
Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging, Fertil. Steril, vol.97, issue.4, pp.843-851, 2012. ,
Haute Autorité de Santé -Cancer du sein : modalités spécifiques de dépistage pour les femmes à haut risque, 2016. ,
Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses' Health Study, Breast Cancer Res. Treat, vol.166, issue.2, pp.613-622, 2017. ,
Accuracy of classification of breast ultrasound findings based on criteria used for BI-RADS, 2008. ,
, Ultrasound Obstet. Gynecol. Off. J. Int. Soc. Ultrasound Obstet. Gynecol, vol.32, issue.4, pp.573-578
, Breast, Examination. In StatPearls. StatPearls Publishing, issue.2, 2018.
, , 2016.
, Cancer Radiother. J. Soc. Francaise Radiother. Oncol, vol.20, pp.139-146
Non-hormonal treatments for menopausal symptoms, BMJ, vol.359, p.5101, 2017. ,
A body image scale for use with cancer patients, Eur. J. Cancer, vol.37, issue.2, pp.189-197, 2001. ,
Quality of Life, Fertility Concerns, and Behavioral Health Outcomes in Younger Breast Cancer Survivors: A Systematic Review, JNCI J. Natl. Cancer Inst, vol.104, issue.5, pp.386-405, 2012. ,
Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies, J. Natl. Cancer Inst, vol.82, issue.7, pp.561-569, 1990. ,
Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study, Int. J. Cancer, vol.46, issue.5, pp.796-800, 1990. ,
Impact of Breast Cancer Subtypes on Prognosis of Women with Operable Invasive Breast Cancer: A Population-based Study Using SEER Database, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, 2018. ,
, Alcohol Consumption and Ethyl Carbamate. International Agency for Research on Cancer, 2010.
, Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy, IARC Monogr. Eval. Carcinog. Risks Hum, vol.91, pp.1-528, 2007.
Antécédents familiaux -Facteurs de risque | Institut National Du Cancer, 2016. ,
INCA -Les cancers en France, 2018. ,
, Anatomie du sein -Cancer du sein, 2019.
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial, International Breast Cancer Study Group, vol.95, issue.24, pp.1833-1846, 2003. ,
Evaluation du programme de dépistage du cancer du sein / Evaluation des programmes de dépistage des cancers / Cancers / Maladies chroniques et traumatismes / Dossiers thématiques / Accueil, 2011. ,
Projection de l'incidence et de la mortalité en France métropolitaine en 2017 -Rapport technique -Ref : RAINCMETRO17, 2018. ,
Smoking and risk of breast cancer in the Generations Study cohort, Breast Cancer Res. BCR, vol.19, 2017. ,
Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis, Mayo Clin. Proc, vol.81, issue.10, pp.1290-1302, 2006. ,
Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer, Int. J. Cancer, vol.49, issue.5, pp.650-655, 1991. ,
Clinical evaluation of chemotherapeutic agents in cancer. In Columbia Univ press. Page 196. MacLeod CM, 1949. ,
Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts, Eur. Radiol, vol.20, issue.3, pp.734-742, 2010. ,
Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.17, issue.9, pp.2932-2940, 1999. ,
Metastatic behavior of breast cancer subtypes, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.28, issue.20, pp.3271-3277, 2010. ,
Neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer, J. Surg. Res, vol.163, issue.1, pp.52-57, 2010. ,
Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies, J. Natl. Cancer Inst, vol.94, issue.8, pp.606-616, 2002. ,
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women, J. Natl. Cancer Inst, vol.95, issue.16, pp.1218-1226, 2003. ,
Metastatic triple negative breast cancer: Optimizing treatment options, new and emerging targeted therapies, Asia Pac. J. Clin. Oncol, vol.14, issue.1, pp.32-39, 2018. ,
Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.28, issue.3, pp.487-496, 2017. ,
Validation of the power model of ovarian nongrowing follicle depletion associated with aging in women, Fertil. Steril, vol.101, issue.3, pp.851-856, 2014. ,
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques, Breast Cancer Res. Treat, vol.131, issue.1, pp.117-126, 2012. ,
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, Lancet Oncol, vol.11, issue.10, pp.70207-70209, 2010. ,
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas, Breast Cancer Res. BCR, vol.9, issue.5, p.65, 2007. ,
Factors influencing the effect of age on prognosis in breast cancer: population based studyCommentary: much still to learn about relations between tumour biology, prognosis, and treatment outcome in early breast cancer, BMJ, vol.320, issue.7233, pp.474-479, 2000. ,
Timing of weight gain and breast cancer risk, Cancer, vol.76, issue.2, pp.243-249, 1995. ,
Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study, Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol, vol.11, issue.11, pp.1375-1381, 2002. ,
Surrogacy of progression free survival for overall survival in metastatic breast cancer studies: Meta-analyses of published studies, Contemp. Clin. Trials, vol.53, pp.20-28, 2017. ,
Menstrual factors and breast cancer risk, Cancer, vol.62, issue.8, pp.1625-1631, 1988. ,
Sem : un outil de gestion informatique et statistique adapté à la recherche en cancérologie, Bull. Cancer (Paris), vol.87, issue.10, pp.715-736, 2000. ,
Prévention et dépistage du cancer du sein, 2018. ,
Body size and breast cancer risk: Findings from the European prospective investigation into cancer and nutrition (EPIC), Int. J. Cancer, vol.111, issue.5, pp.762-771, 2004. ,
Molecular signatures in breast cancer, Methods San Diego Calif, vol.131, pp.135-146, 2017. ,
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.26, issue.12, pp.2408-2419, 2015. ,
, , 2016.
, Gynecol. Obstet. Fertil, vol.44, issue.7-8, pp.424-427
and International Agency for Research on Cancer Handbook Working Group, N. Engl. J. Med, vol.372, issue.24, pp.2353-2358, 2015. ,
Obesity and breast cancer in premenopausal women: Current evidence and future perspectives, Eur. J. Obstet. Gynecol. Reprod. Biol, 2018. ,
Prognostic value of histologic grade nuclear components of Scarff-BloomRichardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas, Cancer, vol.64, issue.9, pp.1914-1921, 1989. ,
American Society of Clinical Oncology recommendations on fertility preservation in cancer patients, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.24, issue.18, pp.2917-2931, 2006. ,
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients, Oncogene, vol.36, issue.9, pp.1211-1222, 2017. ,
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies, J. Clin. Invest, vol.121, issue.7, pp.2750-2767, 2011. ,
Recommendations for evaluating the validity of quality of life claims for labeling and promotion, Value Health J. Int. Soc. Pharmacoeconomics Outcomes Res, vol.2, issue.2, pp.113-127, 1999. ,
MRI in the Assessment of BI-RADS® 4 lesions, Top. Magn. Reson. Imaging TMRI, vol.26, issue.5, pp.191-199, 2017. ,
Prognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosis, Breast Cancer Res. Treat, vol.161, issue.3, pp.537-548, 2017. ,
Le questionnaire MOS SF-36: manuel de l'utilisateur et guide d'interprétation des scores, Editions ESTEM, 2001. ,
Mesure de la santé perceptuelle et de la qualité de vie: méthodes et applications. Editions Estem, 2002. ,
The French SF-36 Health Survey: Translation, Cultural Adaptation and Preliminary Psychometric Evaluation, J. Clin. Epidemiol, vol.51, issue.11, pp.93-99, 1998. ,
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer, JAMA, vol.289, issue.24, pp.3254-3263, 2003. ,
Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy, Oncotarget, vol.8, issue.11, pp.18399-18408, 2017. ,
Progression-Free Survival and Time to Progression as Real Surrogate End Points for Overall Survival in Advanced Breast Cancer: A MetaAnalysis of 37 Trials, Clin. Breast Cancer, vol.18, issue.1, pp.63-70, 2018. ,
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer, Breast Cancer Res. Treat, vol.161, issue.2, pp.279-287, 2017. ,
Desire for a Child and Breast Cancer, Acta Chir. Belg, vol.108, issue.1, pp.83-87, 2008. ,
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.26, issue.8, pp.1275-1281, 2008. ,
ChemotherapyRelated Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles, PloS One, vol.10, issue.10, p.140842, 2015. ,
Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network, Cancer, vol.118, issue.22, pp.5463-5472, 2012. ,
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma, Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc, vol.19, issue.2, pp.264-271, 2006. ,
Prospective Study of Smoking and the Risk of Breast Cancer, JNCI J. Natl. Cancer Inst, vol.81, issue.21, pp.1625-1631, 1989. ,
of Clinical Oncology clinical practice guideline update, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.31, pp.2500-2510, 2013. ,
Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study, The BMJ, vol.342, 2011. ,
Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review, Breast Cancer Res. Treat, vol.132, issue.3, pp.895-915, 2012. ,
Age at first birth and breast cancer risk, Bull. World Health Organ, vol.43, issue.2, pp.209-221, 1970. ,
Body size in different periods of life and breast cancer risk in postmenopausal women, Int. J. Cancer, vol.76, issue.1, pp.29-34, 1998. ,
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials, JAMA, vol.318, issue.10, pp.927-938, 2017. ,
Oral contraceptives and the risk of breast cancer, N. Engl. J. Med, vol.346, issue.26, pp.2025-2032, 2002. ,
Neoadjuvant Chemotherapy Considerations in Triple-Negative Breast Cancer, J. Target. Ther. Cancer, vol.7, issue.1, pp.52-69, 2018. ,
The normal menopause transition, Am. J. Hum. Biol, vol.4, issue.1, pp.37-46, 1992. ,
Reproduction post-chemotherapy in young cancer patients, Mol. Cell. Endocrinol, vol.169, issue.1-2, pp.123-131, 2000. ,
Quality of life : what are the assessment instruments, 2005. ,
Psychological Impact of Alterations in Sexuality, Fertility, and Body Image in Young Breast Cancer Patients and Their Partners, Rev. Investig. Clin. Organo Hosp. Enfermedades Nutr, vol.69, issue.4, pp.204-209, 2017. ,
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, vol.266, issue.5182, pp.66-71, 1994. ,
, Breast cancer and hormone-replacement therapy in the Million Women Study, The Lancet, vol.362, issue.9382, pp.419-427, 2003.
Performing a clinical breast exam : Nursing2013, 2013. ,
Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysis, Eur. J. Cancer, vol.98, pp.48-58, 2018. ,
Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.30, issue.15, pp.1796-1804, 2012. ,
Contemporary Hormonal Contraception and the Risk of Breast Cancer, N. Engl. J. Med, vol.377, issue.23, pp.2228-2239, 2017. ,
Obesity, Body Size, and Risk of Postmenopausal Breast Cancer: The Women's Health Initiative (United States), Cancer Causes Control, vol.13, issue.8, pp.741-751, 2002. ,
Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database, Cancer, vol.110, issue.4, pp.876-884, 2007. ,
Multicentric neoadjuvant phase II study of panitumumab combined with an anthracycline/taxane-based chemotherapy in operable triple-negative breast cancer: identification of biologically defined signatures predicting treatment impact, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.25, issue.8, pp.1570-1577, 2014. ,
Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer, Int. J. Cancer, vol.138, issue.9, pp.2274-2280, 2016. ,
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma, Clin. Cancer Res, vol.10, issue.16, pp.5367-5374, 2004. ,
Facteurs de risque du cancer du sein. médecine/sciences, vol.21, pp.175-180, 2005. ,
Magnetic resonance imaging contrast enhancement of brain tumors at 3 tesla versus 1.5 tesla, Invest. Radiol, vol.37, issue.3, pp.114-119, 2002. ,
Patterns of recurrence after breast-conserving treatment for early stage breast cancer by molecular subtype, J. Breast Cancer, vol.14, issue.1, pp.46-51, 2011. ,
Endocrine therapy in breast cancer: efficacy and adverse events, Rev. Med. Suisse, vol.9, issue.387, pp.1090-1094, 2013. ,
OMS | Constitution de l'OMS: ses principes, 1948. ,
The fate of chemoresistance in triple negative breast cancer (TNBC), BBA Clin, vol.3, pp.257-275, 2015. ,
Age at menopause, cause-specific mortality and total life expectancy, Epidemiol. Camb. Mass, vol.16, issue.4, pp.556-562, 2005. ,
Meat, eggs, dairy products, and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, Am. J. Clin. Nutr, vol.90, issue.3, pp.602-612, 2009. ,
International variation, Oncogene, vol.23, issue.38, pp.6329-6340, 2004. ,
Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer -Preliminary Results From the MENOCOR Study, Clin. Breast Cancer, vol.19, issue.1, pp.74-84, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-01904507
Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triplenegative breast cancer, Breast Cancer Res. Treat, 2019. ,
Lung Metastases Imaging: Practice Essentials, Radiography, Computed Tomography, 2018. ,
Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.27, issue.17, pp.2809-2815, 2009. ,
Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome, Int. J. Oncol, vol.22, issue.6, pp.1319-1325, 2003. ,
Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-752, 2000. ,
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer, N. Engl. J. Med, vol.353, issue.16, pp.1659-1672, 2005. ,
Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up, Histopathology, vol.24, issue.1, pp.41-47, 1994. ,
Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials, Clin. Breast Cancer, vol.19, issue.1, 2019. ,
and PHARE trial investigators. 2013. 6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial, Lancet Oncol, vol.14, issue.8, pp.70225-70225 ,
, Plan Cancer 2014-2019 -Ref : PLANKPNRT14, 2014.
Features of triple-negative breast cancer, Medicine (Baltimore), issue.35, p.95, 2016. ,
Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients, Med. Oncol. Northwood Lond. Engl, vol.30, issue.1, p.388, 2013. ,
Molecular characterization of basal-like and non-basal-like triple-negative breast cancer, The Oncologist, vol.18, issue.2, pp.123-133, 2013. ,
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.15, issue.8, pp.2894-2904, 1997. ,
, Quelques chiffres -Cancer du sein | Institut National Du Cancer, 2018.
Abstract 1819: Heterogeneity of triplenegative breast cancer response to neoadjuvant treatment: tumor EGFR, HER3 and MET expressions can provide clues for therapy tailoring, Cancer Res, vol.74, pp.1819-1819, 2014. ,
Abstract P2-09-29: Potential recurrence markers of locally advanced triple negative breast cancer treated by combined neoadjuvant EGFR targeting and chemotherapy, revealed by genomic analyses and assessment of tumor-infiltrating lymphocytes, Cancer Res, vol.78, pp.2-09, 2018. ,
Metastatic triple-negative breast cancer, Clin. Oncol. R. Coll. Radiol. G. B, vol.23, issue.9, pp.587-600, 2011. ,
BIG 1-98 Collaborative Group, and International Breast Cancer Study Group (IBCSG). 2011. Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up, Lancet Oncol, vol.12, issue.12, pp.1101-1108 ,
Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers, Fertil. Steril, vol.90, issue.5, pp.1635-1639, 2008. ,
Physical Activity and Quality of Life in Older Adults, J. Gerontol. Ser. A, vol.56, issue.suppl_2, pp.23-35, 2001. ,
Socioeconomic risk factors for breast cancer: distinguishing individual-and community-level effects, Epidemiol. Camb. Mass, vol.15, issue.4, pp.442-450, 2004. ,
A novel model for Ki67 assessment in breast cancer, Diagn. Pathol, vol.9, p.118, 2014. ,
A Case-Control Study of Oral Contraceptive Use and Incident Breast Cancer, Am. J. Epidemiol, vol.169, issue.4, pp.473-479, 2009. ,
Reproductive history and breast cancer in a population of high fertility, Costa Rica, 1984-85, Int. J. Cancer, vol.40, issue.6, pp.747-754, 1987. ,
The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy, Stem Cells Dayt. Ohio, vol.16, issue.6, pp.413-428, 1998. ,
and Writing Group for the Women's Health Initiative Investigators. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, JAMA, vol.288, issue.3, pp.321-333 ,
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups, Nature, vol.567, issue.7748, p.399, 2019. ,
Quality of life and sexual functioning in young women with early-stage breast cancer 1 year after lumpectomy, Psychooncology, vol.22, issue.6, pp.1242-1248, 2013. ,
, , 2018.
, Bull. Cancer (Paris), pp.671-678
Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy, Oncotarget, vol.9, issue.41, pp.26406-26416, 2018. ,
Menstrual Cycle Hormone Changes in Women Traversing Menopause: Study of Women's Health Across the Nation, J. Clin. Endocrinol. Metab, vol.102, issue.7, pp.2218-2229, 2017. ,
Menopausal Symptoms and Their Management, Endocrinol. Metab. Clin. North Am, vol.44, issue.3, pp.497-515, 2015. ,
How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment, ESMO Open, vol.2, issue.4, p.208, 2017. ,
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group, Eur. J. Cancer Oxf. Engl, vol.46, issue.8, pp.1296-1316, 1990. ,
Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome, J. Am. Coll. Surg, vol.180, issue.3, pp.297-306, 1995. ,
Which quality of life instruments are preferred by cancer patients in Japan? Comparison of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30 and the Functional Assessment of Cancer Therapy-General. Support. Care Cancer Off, J. Multinatl. Assoc. Support. Care Cancer, vol.22, issue.12, pp.3135-3141, 2014. ,
Li-Fraumeni Syndrome, GeneReviews®, 1993. ,
URL : https://hal.archives-ouvertes.fr/hal-01262929
Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer, Ann. Surg, vol.240, issue.2, pp.306-312, 2004. ,
Age at menopause as a risk factor for cardiovascular mortality, The Lancet, vol.347, issue.9003, pp.90075-90081, 1996. ,
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann. Oncol, vol.26, issue.5, 2015. ,
Signal Transduction in Cancer, p.29, 2015. ,
Total salpingectomy during abdominal hysterectomy: Effects on ovarian reserve and ovarian stromal blood flow, J. Obstet. Gynaecol. Res, vol.33, issue.6, pp.863-869, 2007. ,
Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study, Oncol. Res, vol.23, issue.6, pp.291-302, 2016. ,
Evidence on screening for breast cancer from a randomized trial, Cancer, vol.39, issue.6, pp.2772-2782, 1977. ,
Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening, Natl. Cancer Inst. Monogr, vol.67, pp.65-74, 1985. ,
High Cytoplasmic CXCR4 Expression Predicts Prolonged Survival in Triple-Negative Breast Cancer Patients, J. Pathol. Transl. Med, vol.52, 2018. ,
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science, vol.235, issue.4785, pp.177-182, 1987. ,
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2, N. Engl. J. Med, vol.344, issue.11, pp.783-792, 2001. ,
American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.30, issue.8, pp.880-887, 2012. ,
The Role of Lymphovascular Invasion as a Prognostic Factor in Patients with Lymph NodePositive Operable Invasive Breast Cancer, J. Breast Cancer, vol.14, issue.3, pp.198-203, 2011. ,
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proc. Natl. Acad. Sci. U. S. A, vol.98, pp.10869-10874, 2001. ,
Breast cancer classification and prognosis based on gene expression profiles from a population-based study, Proc. Natl. Acad. Sci. U. S. A, vol.100, issue.18, pp.10393-10398, 2003. ,
Executive summary: stages of reproductive aging workshop (STRAW), Fertil. Steril, vol.76, issue.5, pp.874-878, 2001. ,
The European Organization for Research and Treatment of Cancer breast cancerspecific quality-of-life questionnaire module: first results from a three-country field study, J. Clin. Oncol, vol.14, issue.10, pp.2756-2768, 1996. ,
Predictive factors and patterns of recurrence in patients with triple negative breast cancer, Ann. Surg. Oncol, vol.21, issue.7, pp.2165-2171, 2014. ,
Teenage obesity in relation to breast cancer risk, Int. J. Obes, vol.22, issue.11, 1998. ,
Neoadjuvant and Adjuvant Chemotherapy Considerations for Triple-Negative Breast Cancer, Am. J. Hematol. Oncol, vol.12, issue.3, 2016. ,
Hormone changes associated with the menopausal transition, Minerva Ginecol, vol.61, issue.6, pp.483-489, 2009. ,
Risk Factors and Preventions of Breast Cancer, Int. J. Biol. Sci, vol.13, pp.1387-1397, 2017. ,
Tamoxifen Treatment for Breast Cancer and Risk of Endometrial Cancer: A Case-Control Study, JNCI J. Natl. Cancer Inst, vol.97, issue.5, pp.375-384, 2005. ,
Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.25, issue.28, pp.4414-4422, 2007. ,
Lifetime Cancer Risks in Individuals with Germline PTEN Mutations, Clin. Cancer Res, vol.18, issue.2, pp.400-407, 2012. ,
Correlation between the modified Kupperman Index and the Menopause Rating Scale in Chinese women, Patient Prefer. Adherence, vol.7, pp.223-229, 2013. ,
, Indicateurs d'évaluation / Evaluation du programme de dépistage du cancer du sein / Evaluation des programmes de dépistage des cancers / Cancers / Maladies chroniques et traumatismes / Dossiers thématiques / Accueil, 2018.
Body silhouette, menstrual function at adolescence and breast cancer risk in the E3N cohort study, Br. J. Cancer, vol.92, issue.11, pp.2042-2048, 2005. ,
URL : https://hal.archives-ouvertes.fr/inserm-00127340
Dietary carotenoids and risk of breast cancer, Am. J. Clin. Nutr, vol.76, issue.4, pp.883-888, 2002. ,
Triple Negative Breast Cancer: Outcome Correlation With Immunohistochemical Detection of Basal Markers, Am. J. Surg. Pathol, vol.34, issue.7, pp.956-964, 2010. ,
Chemotherapy-induced ovarian toxicity in patients affected by endocrineresponsive early breast cancer, Crit. Rev. Oncol. Hematol, vol.89, issue.1, pp.27-42, 2014. ,
Menstrual cyclicity and the pre-menopause, Maturitas, vol.3, issue.3, pp.249-264, 1981. ,
Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer, Ann. Surg. Oncol, vol.23, issue.10, pp.3310-3316, 2016. ,
TNM Classification of Malignant Tumours -Google Livres, 2016. ,
VIII. Women's health perception and breast cancer: issues of fertility, hormone substitution, and cancer prevention. Recent Results Cancer Res, Fortschritte Krebsforsch. Progres Dans Rech. Sur Cancer, vol.140, pp.277-283, 1996. ,
Qualité de vie des femmes jeunes ayant un cancer du sein localisé et de leur partenaire : nécessité de développement de questionnaires spécifiques pour la patiente et le partenaire, Bull. Cancer (Paris), vol.99, issue.6, pp.685-691, 2012. ,
The variability of female reproductive ageing, Hum. Reprod. Update, vol.8, issue.2, pp.141-154, 2002. ,
Oral contraceptive use and cancer. Findings in a large cohort study, Br. J. Cancer, vol.95, issue.3, pp.385-389, 1968. ,
Alcohol Consumption as a Risk Factor for Breast Cancer Development: A Case-Control Study in Brazil. Asian Pac, J. Cancer Prev. APJCP, vol.19, issue.3, pp.703-707, 2018. ,
Global Consensus Statement on menopausal hormone therapy, Maturitas, vol.74, issue.4, pp.391-392, 2013. ,
Early menopause: increased fracture risk at older age, Osteoporos. Int, vol.14, issue.6, pp.525-530, 2003. ,
, The Breast: Morphology, Physiology, and Lactation, 2012.
Human Ovarian Reserve from Conception to the Menopause, PLOS ONE, vol.5, issue.1, p.8772, 2010. ,
Incidence of chemotherapy-and chemoradiotherapy-induced amenorrhea in premenopausal women with stage II/III colorectal cancer, Clin. Colorectal Cancer, vol.14, issue.1, pp.31-34, 2015. ,
Effect of nodal status on clinical outcomes of triple-negative breast cancer: a population-based study using the SEER 18 database, Oncotarget, vol.7, issue.29, pp.46636-46645, 2016. ,
Age at menopause, body mass index, and the risk of colorectal cancer mortality in the Dutch Diagnostisch Onderzoek Mammacarcinoom (DOM) cohort, Epidemiol. Camb. Mass, vol.11, issue.3, pp.304-308, 2000. ,
Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual, Life Res. Int. J. Qual. Life Asp. Treat. Care Rehabil, vol.2, issue.2, pp.153-159, 1993. ,
Research on the menopause in the 1990's, 1996. ,
Methods of assessing the impact of climacteric complaints on quality of life, Maturitas, vol.29, issue.1, pp.41-50, 1998. ,
The Second World Cancer Research Fund/American Institute for Cancer Research Expert Report. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective, Proc. Nutr. Soc, vol.67, issue.03, pp.253-256, 2008. ,
College of American Pathologists Clinical Practice Guideline Focused Update, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.36, issue.20, pp.2105-2122, 2018. ,
American Society of Clinical Oncology, and College of American Pathologists. 2013. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.31, issue.31, pp.3997-4013 ,
Identification of the breast cancer susceptibility gene BRCA2, Nature, vol.378, issue.6559, pp.789-792, 1995. ,
, Food, nutrition, physical activity, and the prevention of cancer: a global perspective, vol.1, 2007.
Pattern of Local Recurrence and Distant Metastasis in Breast Cancer By Molecular Subtype, Cureus, vol.8, issue.12, 2016. ,
Physical activity and risk of breast cancer: a metaanalysis of prospective studies, Breast Cancer Res. Treat, vol.137, issue.3, pp.869-882, 2013. ,
Risk, Prediction and Prevention of Hereditary Breast Cancer -Large-Scale Genomic Studies in Times of Big and Smart Data, Geburtshilfe Frauenheilkd, vol.78, issue.05, pp.481-492, 2018. ,
Prognostic role of high neutrophil-to-lymphocyte ratio in breast cancer patients receiving neoadjuvant chemotherapy: Meta-analysis, Medicine (Baltimore), vol.98, issue.1, p.13842, 2019. ,
Untangling the ErbB signalling network, Nat. Rev. Mol. Cell Biol, vol.2, issue.2, pp.127-137, 2001. ,
Summarizing health-related quality of life (HRQOL): development and testing of a one-factor model, Popul. Health Metr, vol.14, 2016. ,
Trastuzumab in the Adjuvant Treatment of HER2-Positive Early Breast Cancer Patients: A Meta-Analysis of Published Randomized Controlled Trials, PLOS ONE, vol.6, issue.6, p.21030, 2011. ,
Prospective study of relative weight and risk of breast cancer: the Breast Cancer Detection Demonstration Project follow-up study, Am. J. Epidemiol, vol.143, issue.10, pp.985-995, 1979. ,
High level of CXCR4 in triplenegative breast cancer specimens associated with a poor clinical outcome, Acta Med. Okayama, vol.67, issue.6, pp.369-375, 2013. ,
Effects of ovarian ablation or suppression in premenopausal breast cancer: A meta-analysis of randomized controlled trials, Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol, vol.43, issue.7, pp.1161-1172, 2017. ,
Managing premature menopause and sexual dysfunction, Curr. Opin. Support. Palliat. Care, vol.9, issue.3, pp.294-300, 2015. ,
, , 1993.